Clinical trials recruiting for Inflammatory Myopathy
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| YTS109 cell | 5 |
| BCMA-CD19 CAR-T therapy | 1 |
| TI-0032-III injection | 1 |
| UCAR T-cell | 1 |
Self-screener
Recruiting trials
- A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases
- A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
- A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases
- A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases
- An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease
- An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases
- BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases
- CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases
- Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases
Related conditions
Trials recruiting for Inflammatory Myopathy often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Inflammatory Myopathy trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.